Article Details

Amgen v. Sanofi: Generally an Attack on Functional Claim Language

Retrieved on: 2021-04-29 13:41:19

Tags for this article:

Click the tags to see associated articles and topics

Amgen v. Sanofi: Generally an Attack on Functional Claim Language. View article details on hiswai:

Excerpt

An isolated monoclonal antibody [that] binds to [one of the residues of PCSK9] and … blocks binding of PCSK9 to LDRL. In its decision, the Federal ...

Article found on: patentlyo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo